| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 16 |
| 1 | PANTOPRAZOLE | 10 |
| 2 | PEMBROLIZUMAB | 10 |
| 3 | LEVETIRACETAM | 9 |
| 4 | AMLODIPINE | 7 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 7 |
| 6 | LEVETIRACETAM INJECTION | 7 |
| 7 | LEVETIRACETAM ORAL | 7 |
| 8 | METHYLPREDNISOLONE | 7 |
| 9 | ASPIRIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARGLUMIC ACID | 1 | 0.0013 |
| 1 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 2 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0011 |
| 3 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0011 |
| 4 | IDECABTAGENE VICLEUCEL | 1 | 0.0008 |
| 5 | ALDESLEUKIN | 1 | 0.0008 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | 1 | 0.0007 |
| 7 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0007 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | 1 | 0.0007 |
| 9 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 31 | 0.0003 |
| 4 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Antimalarial [EPC] | 1 | 0.0001 |
| 9 | Antiprotozoal [EPC] | 1 | 0.0001 |